Group 1 - The company, 创胜集团-B (06628), announced that all conditions for the placement have been met and the completion of the placement occurred on September 17, 2025 [1] - A total of 14.4 million shares were successfully allocated to no less than six subscribers at a placement price of HKD 4.33 per share [1] - The net proceeds from the placement amount to approximately HKD 59.34 million [1]

Group 1 - The core point of the article is that Ying Sheng Science (00209) has engaged in a share placement agreement, raising approximately HKD 10.83 million through the issuance of new shares at a price of HKD 0.350 per share [1] - On September 16, shareholders transferred shares worth HKD 3.7261 million from Hope Securities to Bank of China (Hong Kong), representing 8.45% of the total shares [1] - The share placement involves issuing 30.9515 million new shares, which accounts for about 16.67% of the company's total issued shares post-placement [1] Group 2 - The estimated net proceeds from the placement, after deducting all related expenses, are approximately HKD 10.32 million [1] - The company plans to allocate around 50% of the net proceeds for loan repayment and the other 50% for operational funds and general corporate purposes [1]

Core Viewpoint - Clinique Holdings (08367.HK) announced a placement agreement on September 12, 2025, to issue up to 13.8 million new shares at a price of HKD 0.180 per share, representing a discount of approximately 16.67% compared to the closing price of HKD 0.216 on the same day [1] Group 1 - The placement will be conducted through a placement agent on a best-efforts basis [1] - The net proceeds from the placement, estimated at approximately HKD 2.43 million, will be used for general working capital of the group [1]

Core Viewpoint - Clinique Holdings (08367) announced a placement agreement to issue up to 13.8 million new shares at a price of HKD 0.180 per share, representing a discount of approximately 16.67% from the closing price of HKD 0.216 on September 12, 2025 [1] Summary by Relevant Sections - **Placement Details** - The maximum number of shares to be placed is 13.8 million, which accounts for about 19.99% of the company's total issued share capital of 69.05 million shares as of the announcement date [1] - The net proceeds from the placement are estimated to be approximately HKD 2.43 million, assuming full placement and after deducting all related expenses [1] - **Purpose of the Placement** - The board believes that the placement is a good opportunity to expand the shareholder base and capital base, as well as to raise funds for the group's working capital needs [1] - The terms of the placement agreement are considered fair and reasonable, aligning with the overall interests of the group and its shareholders [1]

配售价每股配售股份0.350港元较于配售协议日期在联交所所报的收市价每股股份0.345港元溢价约 1.45%。 瀛晟科学(00209)发布公告，于2025年9月11日(交易时段后)，公司与配售代理订立配售协议，据此，配 售代理同意按悉数包销基准按每股配售股份0.350港元的价格为及代表公司向不少于六名承配人配售 3095.15万股新股份，占经配售事项扩大后公司已发行股份总数约16.67%。配售股份将根据一般授权配 发及发行。 配售股份的总面值将为30.95万港元。配售事项的所得款项总额将为1083.3万港元。经扣除所有相关开支 后，配售事项的所得款项净额估计约为1032万港元，其约50%拟用作偿还贷款，及约50%拟用作集团营 运资金及一般企业用途。 ...

格隆汇9月11日丨瀛晟科学(00209.HK)公告，于2025年9月11日，公司与配售代理订立配售协议，据此， 配售代理同意按悉数包销基准按每股配售股份0.350港元之价格为及代表公司向不少于六名承配人配售 3095.15万股新股份。配售股份将根据一般授权配发及发行。配售价每股配售股份0.350港元较：(i)于配 售协议日期在联交所所报之收市价每股股份0.345港元溢价约1.45%；及(ii)于紧接配售协议日期前五个 连续交易日在联交所所报每股股份之平均收市价0.377港元折让约7.16%。假设于本公告日期与配售事项 完成之间，公司已发行股本将不会发生变动，配售事项项下之3095.15万股新股份占于本公告日期公司 现有已发行股份总数的20%，及占经配售事项扩大后公司已发行股份总数约16.67%。配售股份之总面值 将为30.95万港元。配售事项之所得款项总额将为1083.3万港元。经扣除所有相关开支后，配售事项之所 得款项净额估计约为1032万港元，其(i)约50%拟用作偿还贷款，及(ii)约50%拟用作本集团营运资金及一 般企业用途。 ...

配售代理已根据配售协议的条款及条件按配售价每股配售股份2.17港元成功配售合共2.76亿股配售股份 予不少于六名独立承配人，该等承配人全部为独立专业投资者、机构投资者及╱或其他个人投资者。据 董事所知、所悉及所信，于本公告日期，各承配人及其各自最终实益拥有人均独立于公司及其关连人 士。公司拟于2027年12月31日或之前将配售所得款项净额约5.97亿港元用作以下用途：(i)4.18亿港元(占 配售所得款项净额总额的70%)将用于开设科技体验店及拓展资产营运领域的新业务;及(ii)1.79亿港元(占 配售所得款项净额总额的30%)将用于一般企业营运资金用途，包括支付管理费用、业务扩展支出、偿 还到期债务等。 首程控股(00697)发布公告，配售协议的先决条件已获达成及配售完成已于2025年9月10日完成。 ...

Core Viewpoint - 嘉进投资国际 (00310.HK) has announced a conditional placement agreement to issue 500 million shares at a price of HKD 0.090 per share, which represents a discount of approximately 10.00% compared to the last trading price of HKD 0.100 on March 28, 2024 [1] Group 1 - The placement will be fully underwritten by the placement agent [1] - The total estimated proceeds from the placement are approximately HKD 45 million, with a net amount of about HKD 42 million after deducting commissions and other related expenses [1] - The net proceeds are intended for investment acquisitions, redemption of convertible bonds, and general working capital of the group [1]

Core Viewpoint - 嘉进投资国际 (00310) plans to issue 500 million shares, representing approximately 80.50% of the company's enlarged issued share capital after the placement [1] Summary by Relevant Sections - **Share Placement Details** - The placement price is set at HKD 0.090 per share, which is about a 10.00% discount compared to the closing price of HKD 0.100 on March 28, 2024 [1] - **Estimated Proceeds** - The total estimated gross proceeds from the placement are approximately HKD 45 million, with net proceeds estimated at HKD 42 million [1] - **Use of Proceeds** - The net proceeds of HKD 42 million are intended for investment acquisitions, redemption of convertible bonds, and general working capital of the group [1]

Core Viewpoint - Honghai High-Tech Resources (00065) announced a conditional placement agreement to issue up to 40.92 million shares at a price of HKD 0.40 per share, representing a discount of approximately 14.89% from the closing price of HKD 0.47 on September 5, 2025 [1] Summary by Relevant Sections - **Placement Details** - The company will place shares to no fewer than six independent third-party subscribers [1] - The placement shares represent about 16.67% of the enlarged issued share capital [1] - **Financial Implications** - If all 40.92 million shares are fully placed, the estimated gross proceeds will be approximately HKD 16.4 million, with net proceeds (after deducting placement commissions and other related expenses) estimated at about HKD 16.1 million [1] - **Use of Proceeds** - The net proceeds from the placement are intended for several potential investment opportunities identified in the mining industry and for general working capital of the group [1]